Kenneth L. Hauser

802 total citations · 1 hit paper
9 papers, 594 citations indexed

About

Kenneth L. Hauser is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Kenneth L. Hauser has authored 9 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Kenneth L. Hauser's work include Synthesis and Reactions of Organic Compounds (4 papers), Estrogen and related hormone effects (2 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). Kenneth L. Hauser is often cited by papers focused on Synthesis and Reactions of Organic Compounds (4 papers), Estrogen and related hormone effects (2 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). Kenneth L. Hauser collaborates with scholars based in United States and Switzerland. Kenneth L. Hauser's co-authors include Jong S. Horng, David T. Wong, Bryan B. Molloy, Frank P. Bymaster, Alan D. Palkowitz, K. Jeff Thrasher, Lorri L. Short, Diane L. Phillips, Masahiko Sato and Henry U. Bryant and has published in prestigious journals such as Journal of Medicinal Chemistry, Life Sciences and Tetrahedron Letters.

In The Last Decade

Kenneth L. Hauser

9 papers receiving 562 citations

Hit Papers

A selective inhibitor of serotonin uptake: Lilly 110140, ... 1974 2026 1991 2008 1974 100 200 300

Peers

Kenneth L. Hauser
Rosemarie Tomlinson United Kingdom
Minhtam Tran United States
Joseph W. Gunnet United States
R.A. O'Brien United States
Steven Z. Whetzel United States
Torsten May Germany
Mah T. Shamim United States
Rosemarie Tomlinson United Kingdom
Kenneth L. Hauser
Citations per year, relative to Kenneth L. Hauser Kenneth L. Hauser (= 1×) peers Rosemarie Tomlinson

Countries citing papers authored by Kenneth L. Hauser

Since Specialization
Citations

This map shows the geographic impact of Kenneth L. Hauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth L. Hauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth L. Hauser more than expected).

Fields of papers citing papers by Kenneth L. Hauser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth L. Hauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth L. Hauser. The network helps show where Kenneth L. Hauser may publish in the future.

Co-authorship network of co-authors of Kenneth L. Hauser

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth L. Hauser. A scholar is included among the top collaborators of Kenneth L. Hauser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth L. Hauser. Kenneth L. Hauser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Norman, Bryan H., Anne H. Dantzig, Julian S. Kroin, et al.. (1999). Reversal of resistance in multidrug resistance protein (MRP1)-overexpressing cells by LY329146. Bioorganic & Medicinal Chemistry Letters. 9(23). 3381–3386. 23 indexed citations
2.
Palkowitz, Alan D., Andrew L. Glasebrook, K. Jeff Thrasher, et al.. (1997). Discovery and Synthesis of [6-Hydroxy-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]- 2-(4-hydroxyphenyl)]benzo[b]thiophene:  A Novel, Highly Potent, Selective Estrogen Receptor Modulator. Journal of Medicinal Chemistry. 40(10). 1407–1416. 144 indexed citations
4.
Palkowitz, Alan D., Mitchell I. Steinberg, Karen M. Zimmerman, et al.. (1995). Synthesis and pharmacological evaluation of a novel series of 5-aryl benzimidazole angiotensin II receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 5(9). 1015–1020. 4 indexed citations
5.
Palkowitz, Alan D., Mitchell I. Steinberg, K. Jeff Thrasher, et al.. (1994). Structural Evolution and Pharmacology of a Novel Series of Triacid Angiotensin II Receptor Antagonists. Journal of Medicinal Chemistry. 37(26). 4508–4521. 21 indexed citations
6.
Steinberg, Mitchell I., Alan D. Palkowitz, K. Jeff Thrasher, et al.. (1994). Chiral recognition of the angiotensin II (AT1) receptor by a highly potent phenoxyproline octanoamide. Bioorganic & Medicinal Chemistry Letters. 4(1). 51–56. 9 indexed citations
7.
Waldmeier, P. C., Serge Bischoff, H. Bittiger, et al.. (1986). Pharmacological Profiles of Four New Tetracyclic Dopamine Antagonists, Maroxepine, Citatepine, Eresepine, and Cipazoxapine. Pharmacopsychiatry. 19(4). 316–317. 9 indexed citations
8.
Wong, David T., Jong S. Horng, Frank P. Bymaster, Kenneth L. Hauser, & Bryan B. Molloy. (1974). A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-Trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine. Life Sciences. 15(3). 471–479. 374 indexed citations breakdown →
9.
Morin, Robert B., D. O. SPRY, Kenneth L. Hauser, & Richard A. Mueller. (1968). Approaches to the chemical synthesis of the prostaglandins. Tetrahedron Letters. 9(57). 6023–6028. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026